CoChat
Sign Up
Cited by 8

Investigating oral nicotine pouch use among adults in Riyadh, Saudi Arabia: prevalence, awareness, susceptibility, and associated symptoms

Alkharaan, Hassan, Alrubayyi, Abdulaziz, Kariri, Majed, Alasqah, Mohammed, Alnufaiy, Banna, Alzahrani, Hanadi G., Gufran, Khalid, Altkhais, Yasser +2 more·2025·Frontiers in Public Health
DOI 10.3389/fpubh.2025.1607656PMC PMC12445106
Open this paper in CoChat — free account

Abstract

Background: Oral nicotine pouches (ONPs) have rapidly gained popularity as a novel nicotine delivery method. However, data on ONP use, awareness, and associated beliefs in Saudi Arabia remain limited. This study aimed to investigate these aspects among adults in Riyadh region. Methods: A cross-sectional survey was conducted in 2024 involving 831 Saudi adults (age ≥ 18 years). Participants completed a self-administered questionnaire assessing ONP awareness, prevalence, beliefs, and susceptibility as well as potential associated ONP use symptoms. Logistic and multinomial regression models were employed to analyze the associations between these variables. Results: Overall, 59.3% of participants reported awareness of ONPs, and 14.2% having used them. Males were more aware (ORadj = 1.97, p < 0.0001) and user (ORadj = 2.86, p = 0.03) of ONP than females. Similarly, younger adults (aged 18–29 and 30–39 years) demonstrated higher ONP awareness (ORadj = 4.67 and 4.88, respectively, both p < 0.0001) and use (ORadj = 6.91, p < 0.002 and 6.12, p < 0.003, respectively) compared to older adults (40–69 years). Additionally, 95.8% of ONP users were smokers, more likely to be cigarette (ORadj = 9.53, p < 0.0001) or e-cigarette (ORadj = 8.43, p < 0.0001) smokers. Approximately 60% of participants demonstrated susceptibility to ONP use, characterized by curiosity, limited knowledge of health risks, and potential willingness to use. Favorable beliefs about ONPs were more prevalent among users. Furthermore, a positive correlation was observed between the frequency of ONP use and the likelihood of experiencing associated symptom ( r = 0.3, p = 0.0009), with abdominal symptoms being the most reported symptom. Conclusion: Given that 95.8% of ONP users in this study were smokers, these findings suggest a potential future role for ONPs as a harm reduction strategy within the context of smoking cessation in Saudi population in Riyadh. However, continuous surveillance and targeted public health interventions are crucial to mitigate the potential negative consequences associated with ONP use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpubh.2025.1607656

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. [3]GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. (2020) 396: 1223– 49. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30752-2/fulltext 33069327 PMC7566194
  2. [4]Bilano V Gilmour S Moffiet T D’Espaignet ET Stevens GA Commar A. Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet. (2015) 385: 966– 76. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60264-1/fulltext 25784347
  3. [5]Ramôa CP Eissenberg T Sahingur SE. Increasing popularity of waterpipe tobacco smoking and electronic cigarette use: implications for oral healthcare. J Periodontal Res. (2017) 52: 813– 23. doi: 10.1111/jre.12458 28393367 PMC5585021 · DOI
  4. [6]Bialous SA Glantz SA. Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control. Tob Control. (2018) 27: s111– 7. doi: 10.1136/tobaccocontrol-2018-054340, PMID: 30209207 PMC6202178 · DOI
  5. [7]Azzopardi D Liu C Murphy J. Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums. Drug Chem Toxicol. (2022) 45: 2246– 54. doi: 10.1080/01480545.2021.1925691, PMID: 34034614 · DOI · Paper page
  6. [9]Robichaud MO Seidenberg AB Byron MJ. Tobacco companies introduce “tobacco-free” nicotine pouches. Tob Control [Internet]. (2020). 29: e145– 6. Available at: https://tobaccocontrol.bmj.com/content/29/e1/e145 PMC7239723 31753961
  7. [11]East N Bishop E Breheny D Gaca M Thorne D. A screening approach for the evaluation of tobacco-free ‘modern oral’ nicotine products using real time cell analysis. Toxicol Rep. (2021) 8: 481– 8. doi: 10.1016/j.toxrep.2021.02.014, PMID: 33718000 PMC7933807 · DOI
  8. [12]Gholap VV Kosmider L Golshahi L Halquist MS. Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes? Expert Opin Drug Deliv. (2020) 17: 1727– 36. Available at: https://www.tandfonline.com/doi/full/10.1080/17425247.2020.1814736 32842785 PMC9361466 · DOI
  9. [13]Majmundar A Okitondo C Xue A Asare S Bandi P Nargis N. Nicotine pouch sales trends in the US by volume and nicotine concentration levels from 2019 to 2022. JAMA Netw Open. (2022) 5: e2242235. Available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798449 36378312 PMC9667333
  10. [14]Lyu JC Ozga JE Stanton CA Hrywna M Ganz O Cornacchione Ross J. Advertising the leading US nicotine pouch brand: a content analysis of ZYN advertisements from 2019 to 2023. Tob Control [Internet]. (2025). tc-2024-059145. Available at: https://tobaccocontrol.bmj.com/content/early/2025/05/06/tc-2024-059145 PMC12379097 40335264
  11. [15]Stanfill S Tran H Tyx R Fernandez C Zhu W Marynak K. Characterization of Total and Unprotonated (free) nicotine content of nicotine pouch products. Nicotine Tobacco Research. (2021) 23: 1590– 6. doi: 10.1093/ntr/ntab030, PMID: 34233354 · DOI
  12. [16]Lawler TS Stanfill SB Zhang L Ashley DL Watson CH. Chemical characterization of domestic oral tobacco products: Total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines. Food Chem Toxicol. (2013) 57: 380– 6. doi: 10.1016/j.fct.2013.03.011, PMID: 23517910 PMC5659123 · DOI
  13. [20]IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines [Internet]. Vol. 89, IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer. Lyon (FR): International Agency for Research on Cancer; (2007). 1–592. Available at: https://www.ncbi.nlm.nih.gov/books/NBK326497/ PMC4781254 18335640
  14. [21]Vishwakarma A Verma D. Microorganisms: crucial players of smokeless tobacco for several health attributes. Appl Microbiol Biotechnol. (2021). 105: 6123– 32. doi: 10.1007/s00253-021-11460-2, PMID: 34331556 · DOI
  15. [22]Mallock N Schulz T Malke S Dreiack N Laux P Luch A. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches. Tob Control. (2024) 33: 193– 9. Available at: https://tobaccocontrol.bmj.com/content/33/2/193 38378209
  16. [24]Mallock-Ohnesorg N Rabenstein A Stoll Y Gertzen M Rieder B Malke S. Small pouches, but high nicotine doses—nicotine delivery and acute effects after use of tobacco-free nicotine pouches. Front Pharmacol. (2024) 15: 1– 12. doi: 10.3389/fphar.2024.1392027, PMID: 38841367 PMC11150668 · DOI
  17. [25]Morean ME Bold KW Davis DR Kong G Krishnan-Sarin S Camenga DR. Awareness, susceptibility, and use of oral nicotine pouches and comparative risk perceptions with smokeless tobacco among young adults in the United States. PLoS One. (2023) 18: 1– 12. doi: 10.1371/journal.pone.0281235 PMC9886243 36716297 · DOI
  18. [26]Pierce JP Choi WS Gilpin EA Farkas AJ Merritt RK. Validation of susceptibility as a predictor of which adolescents take up smoking in the United States. Health Psychol. (1996) 15: 355– 61. 8891714
  19. [27]Sparrock LS Phan L Chen-Sankey J Hacker K Ajith A Jewett B. Nicotine pouch: awareness, beliefs, use, and susceptibility among current tobacco users in the United States, 2021. Int J Environ Res Public Health. (2023) 20:2050. doi: 10.3390/ijerph20032050, PMID: 36767414 PMC9915420 · DOI
  20. [29]La Rosa GRM Fagerström K Pacino SA Kowalski J Górska R Gospodaru S. Self-reported oral health outcomes after switching to a novel nicotine pouch technology: a pilot study. Acta Odontol Scand. (2025) 84: 292– 8. doi: 10.2340/aos.v84.43805, PMID: 40422555 PMC12138386 · DOI · Paper page
  21. [32]Felicione NJ Schneller LM Goniewicz ML Hyland AJ Cummings KM Bansal-Travers M. Oral nicotine product awareness and use among people who smoke and vape in the U.S. Am J Prev Med. (2022) 63: 611– 8. doi: 10.1016/j.amepre.2022.04.019, PMID: 35667923 PMC9509436 · DOI
  22. [33]Hrywna M Gonsalves NJ Delnevo CD Wackowski OA. Nicotine pouch product awareness, interest and ever use among US adults who smoke, 2021. Tob Control. (2023) 32: 782– 5. doi: 10.1136/tobaccocontrol-2021-057156, PMID: 35217596 PMC9402802 · DOI
  23. [34]Elsokkary EM Alsabhan FA Alyahya AA Alsahli SA Almousa AM Aldali JA. Exploring the effect of nicotine pouches on users’ health in Saudi Arabia: a cross-sectional study. Tob Induc Dis. (2025) 23: 1– 6. doi: 10.18332/tid/203510, PMID: 40352804 PMC12063099 · DOI
  24. [35]Keller-Hamilton B Alalwan MA Curran H Hinton A Long L Chrzan K. Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and Appalachian adults who smoke cigarettes: a randomized cross-over study. Addiction. (2024) 119: 464– 75. doi: 10.1111/add.16355, PMID: 37964431 PMC10872395 · DOI · Paper page
  25. [37]Vogel EA Barrington-Trimis JL Kechter A Tackett AP Liu F Sussman S. Differences in young adults’ perceptions of and willingness to use nicotine pouches by tobacco use status. Int J Environ Res Public Health. (2022) 19:2685. doi: 10.3390/ijerph19052685, PMID: 35270385 PMC8910652 · DOI
  26. [38]Rungraungrayabkul D Gaewkhiew P Vichayanrat T Shrestha B Buajeeb W. What is the impact of nicotine pouches on oral health: A systematic review, vol. 24. BioMed Central Ltd: BMC Oral Health (2024). PMC11297755 39097712
  27. [39]Alizadehgharib S Lehrkinder A Alshabeeb A Östberg AK Lingström P. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus). Eur J Oral Sci. (2022) 130: e12885. doi: 10.1111/eos.12885, PMID: 35853092 PMC9540014 · DOI
  28. [40]Miluna S Melderis R Briuka L Skadins I Broks R Kroica J. The correlation of Swedish snus, nicotine pouches and other tobacco products with Oral mucosal health and salivary biomarkers. Dent J. (2022) 10:154. doi: 10.3390/dj10080154, PMID: 36005252 PMC9406994 · DOI · Paper page
  29. [41]Johnson GK Guthmiller JM Joly S Organ CC Dawson DV. Interleukin-1 and interleukin-8 in nicotine- and lipopolysaccharide-exposed gingival keratinocyte cultures. J Periodontal Res. (2010) 45: 583– 8. PMID: 20337880
  30. [42]Kubota M Yanagita M Mori K Hasegawa S Yamashita M Yamada S. The effects of cigarette smoke condensate and nicotine on periodontal tissue in a periodontitis model mouse. PLoS One. (2016) 11:e0155594. doi: 10.1371/journal.pone.0155594, PMID: 27203240 PMC4874667 · DOI
  31. [43]Bosco AF. A histologic and histometric assessment of the influence of nicotine on alveolar bone loss in rats. J Periodontol. (2007) 78: 527– 32. doi: 10.1902/jop.2007.060149, PMID: 17335377 · DOI
  32. [44]Liu J Edmiston JS Wang J Milleman KR Milleman JL Yoder AL. Oral health effects among adults switching from cigarettes to on!® nicotine pouches compared to those who continue smoking. Oral Health Prev Dent. (2025) 23: 189– 201. 40130808 PMC11966149
  33. [45]Edmiston J Liu J Wang J Sarkar M. A randomized, controlled study to assess biomarkers of exposure in adult smokers switching to Oral nicotine products. J Clin Pharmacol. (2022) 62: 1445– 58. doi: 10.1002/jcph.2098, PMID: 35730535 PMC9804531 · DOI

Cited by

Sorted by citations

Authors
Alkharaan, H., Alrubayyi, A., Kariri, M., Alasqah, M., Alnufaiy, B., Alzahrani, H. G., Gufran, K., Altkhais, Y., Algharbi, M., & Alarfaj, F.
Venue
Frontiers in Public Health
Publisher
Frontiers Media SA
Published
2025-09-04
Volume
13
ISSN
2296-2565
DOI
10.3389/fpubh.2025.1607656
PMC
PMC12445106
Cited by
8
References
1
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review